Gebauer, F., Schwarzl, T., Valcarcel, J
The mean percentage change in body weight from baseline to 68 weeks was 14.9% in the semaglutide group versus 2.4% in the placebo group
Routine cost or convenience doesnt qualify
Mounjaro is the brand-name formulation of tirzepatide, designed with specific dosing, delivery mechanisms, and clinical testing to ensure efficacy and safety
You may experience side effects, while others may not
When combined with the exclusion of patients with either acute or chronic pancreatitis from prior clinical trials, this observation aligns with the caution raised by the American Diabetes Association to avoid use of GLP-1RAs for patients with any history of acute or chronic pancreatitis 27